These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33915217)

  • 21. Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer.
    Wolfson AH; Bae K; Komaki R; Meyers C; Movsas B; Le Pechoux C; Werner-Wasik M; Videtic GM; Garces YI; Choy H
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):77-84. PubMed ID: 20800380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rational and design of prophylactic cranial irradiation (PCI) and brain MRI surveillance versus brain MRI surveillance alone in patients with limited-stage small cell lung cancer achieving complete remission (CR) of tumor after chemoradiotherapy: a multicenter prospective randomized study.
    Chen M; Li R; Kong Y; Shi L; Wang J; Wang Y; Xu Y; Ji Y; Hu X
    BMC Cancer; 2024 Apr; 24(1):429. PubMed ID: 38589800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial.
    Brahmer JR; Rodríguez-Abreu D; Robinson AG; Hui R; Csőszi T; Fülöp A; Gottfried M; Peled N; Tafreshi A; Cuffe S; O'Brien M; Rao S; Hotta K; Zhang J; Lubiniecki GM; Deitz AC; Rangwala R; Reck M
    Lancet Oncol; 2017 Dec; 18(12):1600-1609. PubMed ID: 29129441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-Reported Cognitive Function and Quality of Life in Patients With SCLC in the Hippocampal Avoidance Prophylactic Cranial Irradiation Versus Prophylactic Cranial Irradiation Randomized Phase 3 Trial (NCT01780675).
    Albers EAC; Zeng H; De Ruysscher DKM; Kuenen MA; Kessels R; Hendriks LEL; Belderbos JSA; Schagen SB
    JTO Clin Res Rep; 2023 May; 4(5):100506. PubMed ID: 37284297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Present role of prophylactic cranial irradiation].
    Le Péchoux C; Al Mohkles H; Dhermain F
    Bull Cancer; 2013 Jan; 100(1):35-43. PubMed ID: 23306141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international Phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer Groups.
    Slotman BJ; Mauer ME; Bottomley A; Faivre-Finn C; Kramer GW; Rankin EM; Snee M; Hatton M; Postmus PE; Collette L; Senan S
    J Clin Oncol; 2009 Jan; 27(1):78-84. PubMed ID: 19047288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health-related quality of life in the randomized phase III trial of brigatinib vs crizotinib in advanced ALK inhibitor-naive ALK + non-small cell lung cancer (ALTA-1L).
    Garcia Campelo MR; Lin HM; Zhu Y; Pérol M; Jahanzeb M; Popat S; Zhang P; Camidge DR
    Lung Cancer; 2021 May; 155():68-77. PubMed ID: 33744781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for neurocognitive decline in lung cancer patients treated with prophylactic cranial irradiation: A systematic review.
    Zeng H; Hendriks LEL; van Geffen WH; Witlox WJA; Eekers DBP; De Ruysscher DKM
    Cancer Treat Rev; 2020 Aug; 88():102025. PubMed ID: 32512415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial.
    Takahashi T; Yamanaka T; Seto T; Harada H; Nokihara H; Saka H; Nishio M; Kaneda H; Takayama K; Ishimoto O; Takeda K; Yoshioka H; Tachihara M; Sakai H; Goto K; Yamamoto N
    Lancet Oncol; 2017 May; 18(5):663-671. PubMed ID: 28343976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality of life results from a randomized, double-blinded, placebo-controlled, multi-center phase III trial of anlotinib in patients with advanced non-small cell lung cancer.
    Si X; Zhang L; Wang H; Zhang X; Wang M; Han B; Li K; Wang Q; Shi J; Wang Z; Cheng Y; He J; Shi Y; Chen W; Wang X; Luo Y; Nan K; Jin F; Li B; Chen Y; Zhou J; Wang D
    Lung Cancer; 2018 Aug; 122():32-37. PubMed ID: 30032842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy.
    Langendijk H; Aaronson NK; de Jong JM; ten Velde GP; Muller MJ; Wouters M
    Radiother Oncol; 2000 Apr; 55(1):19-25. PubMed ID: 10788684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study.
    Hui R; Özgüroğlu M; Villegas A; Daniel D; Vicente D; Murakami S; Yokoi T; Chiappori A; Lee KH; de Wit M; Cho BC; Gray JE; Rydén A; Viviers L; Poole L; Zhang Y; Dennis PA; Antonia SJ
    Lancet Oncol; 2019 Dec; 20(12):1670-1680. PubMed ID: 31601496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiinstitutional prospective observational study of stereotactic radiosurgery for patients with multiple brain metastases from non-small cell lung cancer (JLGK0901 study-NSCLC).
    Shuto T; Akabane A; Yamamoto M; Serizawa T; Higuchi Y; Sato Y; Kawagishi J; Yamanaka K; Jokura H; Yomo S; Nagano O; Aoyama H
    J Neurosurg; 2018 Dec; 129(Suppl1):86-94. PubMed ID: 30544291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective Study of Hippocampal-Sparing Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung Cancer.
    Redmond KJ; Hales RK; Anderson-Keightly H; Zhou XC; Kummerlowe M; Sair HI; Duhon M; Kleinberg L; Rosner GL; Vannorsdall T
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):603-611. PubMed ID: 28581401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized phase III trial of prophylactic cranial irradiation versus observation in patients with fully resected stage IIIA-N2 nonsmall-cell lung cancer and high risk of cerebral metastases after adjuvant chemotherapy.
    Li N; Zeng ZF; Wang SY; Ou W; Ye X; Li J; He XH; Zhang BB; Yang H; Sun HB; Fang Q; Wang BX
    Ann Oncol; 2015 Mar; 26(3):504-9. PubMed ID: 25515658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
    Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
    Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylactic Cranial Irradiation for Limited-Stage Small-Cell Lung Cancer Patients: Secondary Findings From the Prospective Randomized Phase 3 CONVERT Trial.
    Levy A; Le Péchoux C; Mistry H; Martel-Lafay I; Bezjak A; Lerouge D; Padovani L; Taylor P; Faivre-Finn C
    J Thorac Oncol; 2019 Feb; 14(2):294-297. PubMed ID: 30292850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term quality of life in early-stage non-small cell lung cancer patients treated with robotic stereotactic ablative radiation therapy.
    Mathieu D; Campeau MP; Bahig H; Larrivée S; Vu T; Lambert L; Lavoie C; Roberge D; Doucet R; Carrier JF; Gorgos A; Fortin B; Filion E
    Pract Radiat Oncol; 2015; 5(4):e365-73. PubMed ID: 25680997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. External irradiation versus external irradiation plus endobronchial brachytherapy in inoperable non-small cell lung cancer: a prospective randomized study.
    Langendijk H; de Jong J; Tjwa M; Muller M; ten Velde G; Aaronson N; Lamers R; Slotman B; Wouters M
    Radiother Oncol; 2001 Mar; 58(3):257-68. PubMed ID: 11230886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomised trial. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) and the European Organization for Research and Treatment of Cancer (EORTC).
    Gregor A; Cull A; Stephens RJ; Kirkpatrick JA; Yarnold JR; Girling DJ; Macbeth FR; Stout R; Machin D
    Eur J Cancer; 1997 Oct; 33(11):1752-8. PubMed ID: 9470828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.